๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Tumorigenicity of BALB3T3 A31 cells transfected with hamster-complement-C1s cDNA

โœ Scribed by Norie Sakai; Mayumi Kusunoki; Munehiro Nishida; Toru Toyoguchi; Hisayuki Fukutomi; Hisako Sakiyama


Book ID
102866934
Publisher
John Wiley and Sons
Year
1994
Tongue
French
Weight
633 KB
Volume
58
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

โœฆ Synopsis


Hamster-complement-C I s cDNA was inserted into an expression plasmid BCMGSNeo (BCMGSNeoHACS). BALBIc mouse fibroblast A31 cells, which do not produce CIS, were transfected with BCMGSNeoHACS and the transfectants were selected with G418. Normal CIS production by the transfectants was confirmed by Northern and immunoblot analysis and by an esterase assay. To examine the tumorigenicity of the transfectants, I x lo6 cells were injected S.C. into 6-week-old BALBIc nulnu mice. Three C I S cDNA transfectants (A3CS9, A3CS 12, A3CS 13) formed tumors whereas both A3 I and A3 I transfected with the vector alone (A3BCMI and A3BCM3) did not. The tumors derived from the transfectants showed invasive growth, and many capillaries were observed in the tumors. A tumor derived from A3CS I3 was examined immunohistochemically and found to be reactive with an anti-CIS monoclonal antibody. Tumor cells were cultured in vitro again and C I S secreted into the culture medium was examined by immunoblot analysis. C I s synthesized by the tumor cells derived from A3CS I3 maintained its biological functions. Tumor cells derived from A3CS9 and A3CS I 2 cells, however, produced C I s having abnormal disulfide bonds.


๐Ÿ“œ SIMILAR VOLUMES


Site-directed mutagenesis of hamster com
โœ Hisako Sakiyama; Munehiro Nishida; Norie Sakai; Ken Nagino; Shoichiro Miyatake; ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 528 KB

We have previously shown that non-transformed mouse A3 I cells became tumorigenic when they were transfected with hamster C I s cDNA expression plasmid BCMGSNeoCS. In the present study, mutations were introduced into the cDNA at the activation cleavage site, Arg423(AGG) and the active center Ser6 I'